Real-world Use of Mold-Active Triazole Prophylaxis in the Prevention of Invasive Fungal Diseases: Results From a Subgroup Analysis of a Multicenter National Registry.

Nguyen, M Hong; Ostrosky-Zeichner, Luis; Pappas, Peter G; Walsh, Thomas J; Bubalo, Joseph; Alexander, Barbara D; Miceli, Marisa H; Jiang, Jeanette; Song, Yi; Thompson, George R

Nguyen, M Hong; Ostrosky-Zeichner, Luis; Pappas, Peter G; Walsh, Thomas J; Bubalo, Joseph; Alexander, Barbara D; Miceli, Marisa H; Jiang, Jeanette; Song, Yi; Thompson, George R.

Afiliación

Nguyen MH; University of Pittsburgh, Pittsburgh, Pennsylvania, USA.
Ostrosky-Zeichner L; McGovern Medical School, Houston, Texas, USA.
Pappas PG; University of Alabama at Birmingham, Birmingham, Alabama, USA.
Walsh TJ; Weill Cornell Medicine, Cornell University, New York, New York, USA.
Bubalo J; Institute for Innovative Therapeutics and Diagnostics, Richmond, Virginia, USA.
Alexander BD; Oregon Health and Science University Hospital and Clinics, Portland, Oregon, USA.
Miceli MH; Duke University, Durham, North Carolina, USA.
Jiang J; University of Michigan, Ann Arbor, Michigan, USA.
Song Y; Astellas Pharma Global Development, Inc., Northbrook, Illinois, USA.
Thompson GR; Astellas Pharma Global Development, Inc., Northbrook, Illinois, USA.

Open Forum Infect Dis ; 10(9): ofad424, 2023 Sep.

Article en En | MEDLINE | ID: mdl-37674634

Palabras clave

antifungal prophylaxis; isavuconazole; posaconazole; real-world; voriconazole

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Tipo de estudio: Clinical_trials / Risk_factors_studies Idioma: En Revista: Open Forum Infect Dis Año: 2023 Tipo del documento: Article País de afiliación: Estados Unidos

Texto completo

Imprimir

XML

PubMed Links

Buscar en Google